VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,804,749 | +74.4% | 313,217 | +170.5% | 0.00% | 0.0% |
| Q2 2023 | $2,754,573 | +4.0% | 115,787 | +11.3% | 0.00% | 0.0% |
| Q1 2023 | $2,647,541 | -11.3% | 104,070 | +1.8% | 0.00% | 0.0% |
| Q4 2022 | $2,986,430 | +97.9% | 102,240 | +39.0% | 0.00% | 0.0% |
| Q3 2022 | $1,509,000 | +91.0% | 73,549 | +7.8% | 0.00% | – |
| Q2 2022 | $790,000 | – | 68,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |